Trial Details
TERMINATEDBasic Information
| Clinical ID | c1784 |
|---|---|
| Identifier | NCT03656627 |
| Trial Title | Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Autoimmune Diseases|Non-small Cell Lung Cancer|Rheumatoid Arthritis|Psoriasis|Giant Cell Arteritis|Polymyalgia Rheumatica|Systemic Lupus Erythematosus|Crohn Disease|Multiple Sclerosis|Ulcerative Colitis |
| Interventions | DRUG: Nivolumab |
Participant Information
| Sponsor | Alliance Foundation Trials, LLC. |
|---|---|
| City | Chicago |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2019-06-27 |
|---|---|
| Primary Completion Date | 2021-03-18 |
| Completion Date | 2021-03-18 |